Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00631852 · ClinicalTrials.gov registry record · Phase 2
A Phase II Biomarker Trial of Gelatin Encapsulated Extract of American Ginseng Root (LEAG) in Breast Cancer
A Phase 2 study, sponsored by Southern Illinois University.
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT00631852 is a Phase 2 study that has completed, run by Southern Illinois University. The registered enrollment target is 16 participants.
The verdict
NCT00631852, a Phase 2 study, has completed, sponsored by Southern Illinois University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
This study was designed to explore the changes brought about by gelatin encapsulated extract of American Ginseng Root (LEAG) in breast cancer tumors and surrounding normal breast epithelial cells. Various tumor biomarkers, as well as inflammatory mediators, will be examined in tissue following LEAG treatment.
Interventions
- DRUG American Ginseng root
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2008-02 |
| Est. Completion | 2019-06-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00631852
The ClinicalTrials.gov registry entry for NCT00631852 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Southern Illinois University, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which American Ginseng root is the first listed.
NCT00631852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00631852 about?
NCT00631852 is a clinical study titled "A Phase II Biomarker Trial of Gelatin Encapsulated Extract of American Ginseng Root (LEAG) in Breast Cancer". This study was designed to explore the changes brought about by gelatin encapsulated extract of American Ginseng Root (LEAG) in breast cancer tumors and surrounding normal breast epithelial cells. Various tumor biomarkers, as well as inflammatory mediators, will be examined in tissue following LEAG ...
What is the current status of trial NCT00631852?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2008-02. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT00631852?
The interventions under investigation include: American Ginseng root (DRUG).
Who is sponsoring clinical trial NCT00631852?
This trial is sponsored by Southern Illinois University, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.